Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
NVO
NVO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NVO News
Eli Lilly's GLP-1 Drug Sales Surge
21h ago
Fool
Eli Lilly's GLP-1 Drug Sales Surge Amid Competition
21h ago
NASDAQ.COM
Eli Lilly's Tirzepatide Shows Superior Weight Loss Effects Compared to Semaglutide
2d ago
seekingalpha
Novo Nordisk and Eli Lilly Prescription Comparison
2d ago
stocktwits
Eli Lilly's Weight-Loss Drug Off to Slow Start in U.S. Market
2d ago
Yahoo Finance
Eli Lilly's Foundayo Prescriptions Surge Post Launch
2d ago
seekingalpha
Viking Therapeutics: A Potential Obesity Market Leader
2d ago
Fool
Viking Therapeutics Targets Billion-Dollar Obesity Market
2d ago
NASDAQ.COM
Novo Nordisk Plans to Add 2,000 Employees Amid Restructuring
2d ago
Yahoo Finance
CNBC Investing Club April Meeting Highlights
2d ago
CNBC
Investment Comparison: CVS Health vs. Novo Nordisk
3d ago
Fool
Novo Nordisk Expands Workforce by 2,000 Amid Restructuring
3d ago
seekingalpha
FDA Reviews Peptide Substances, HIMS Stock Surges
3d ago
stocktwits
Eli Lilly Leads U.S. Weight Loss Drug Market
3d ago
Fool
Eli Lilly Surpasses Novo Nordisk as U.S. Weight Loss Drug Leader
3d ago
NASDAQ.COM
India's E-commerce Market Experiences Rapid Growth
3d ago
CNBC
Show More News
